Under the leadership of AdventHealth Heart, Lung and Vascular Institute interventional cardiologist Rohit Bhatheja, MD, MBA, FACC, FSCAI, AdventHealth Orlando became the first in Central Florida to randomize a patient in the ALLAY-HF clinical trial on January 15, 2024. The study is a global, double-blinded, randomized, sham-controlled trial to demonstrate the safety and effectiveness of the Alleviant System for the treatment of chronic heart failure through left atrial decompression.
The ALLAY-HF trial targets patients suffering from heart failure with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction who have heart failure symptoms despite appropriate medical therapy. The Alleviant System is a novel technology intended to address these patients’ needs through decompression of the left atrium using a minimally invasive, percutaneous approach without leaving behind any implant.
“Many heart failure patients are left without options if they do not experience relief of their symptoms after significant lifestyle changes and complex medication regimens,” explains Dr. Bhatheja. “We are excited to explore the potential of percutaneous left atrial decompression to give these patients a chance at a better quality of life without the risk of leaving an implant behind in the heart.”
How the Alleviant System Works
The Alleviant System was granted U.S. FDA Breakthrough Device Designation in 2021. It is an investigational medical device that creates a connection between the left and right atrial chambers of the heart through a single procedure without leaving a permanent implant behind. The procedure is intended to reduce excess pressure buildup within the heart, which may reduce symptoms of heart failure such as shortness of breath, fatigue, weakness and swelling in the legs or belly.
About Chronic Heart Failure
Chronic heart failure (CHF) is a progressive disease that affects 26 million patients worldwide and is the leading cause of hospitalizations worldwide, resulting in a significant economic burden to the healthcare system. Common symptoms of CHF include shortness of breath during exertion (or at rest), inability to perform daily activities (walking, climbing stairs), fatigue and weakness, and swelling in the legs, ankles, feet or belly. Despite medications available for management of heart failure, many patients still experience debilitating symptoms, frequent hospitalization and reduced quality of life.
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
News
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
News
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
News
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
News
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
News
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
News
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
News
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
News
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at...
News
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
AdventHealth East Orlando recently became the first hospital in Florida to earn Advanced Foot & Ankle Surgery Certification from DNV, a worldwide, independent certification body.
News
Recent Study on How Physical Activity May Boost Neurocognition in Late Adulthood Featured in the Medical Journal Age and Ageing
In a new article published in the medical journal Age and Ageing, AdventHealth Research Institute’s Dr. Audrey Collins shares the results of a recent study evaluating the impact of exercise on...
News
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism and co-authored by Dr. Corbin introduces a metagenomics-powered approach to...